If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetro Matad Regulatory News (MATD)

Share Price Information for Petro Matad (MATD)

Share Price is delayed by 15 minutes
Get Live Data
1.10    0.00 (0.00%)
Bid:
1.05
Ask:
1.15
Spread: 0.10 (9.524%)
Market Cap: £20.45m
MATD Live PriceLast checked at - London Stock Exchange

Intraday Petro Matad Share Chart

Progressive publishes new research

19 Jan 2022 07:18

RNS Number : 9384Y
Petro Matad Limited
19 January 2022
 

Promising outlook for 2022 - Heron moving ahead

 

Petro Matad issued a trading update in December highlighting that the company is on track for its target of starting production at its Heron oil discovery in Mongolia in the middle of 2022. The Heron field is located in Block XX, where the company has a 100% working interest. This production will allow Petro Matad to start generating cash flow, which will give the company the funds required to accelerate its anticipated work programme.

 

 

Click here for full analysis

 

Subscribe to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement. 

About Progressive:

 

Progressive is an equity research and investor engagement company. FCA authorised and regulated, the firm has a 15-strong team of highly experienced analysts. We provide Institutional grade research and connect companies with investors across every sector of the market.

 

www.progressive-research.com

 

Broad coverage

 

Analyst calibre

 

across 12 sectors

 

 

 

 

 

 

Business Services

Oil & Gas

15analysts

with average

20years

Financials

Property

experience of

Healthcare

Retail

Industrials

Technology

30+

techMARK

Investment Trusts

Telecoms

industry based

Extel

Mining

Utilities

awards

StarMine

 

For further information please contact:

 

Keith Hodgskiss

+44 (0) 20 7781 5300

khodgskiss@progressive-research.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAXFNFFKAEEA
Date   Source Headline
18th Jan 202211:00 amRNSPrice Monitoring Extension
15th Dec 20217:00 amRNSConditional Share Awards and Total Voting Rights
7th Dec 20217:00 amRNSOperational Update
15th Sep 20217:00 amRNSInterim Results
2nd Sep 20217:07 amRNSInvestor Presentation
5th Aug 202111:53 amRNSVoting Results from EGM
5th Aug 20217:00 amRNSOutcome of Open Offer, EGM and Advisor Appointment
2nd Aug 20217:00 amRNSReceipt of subscription funding and loan repayment
19th Jul 20217:00 amRNSLaunch of Open Offer
15th Jul 20219:05 amRNSSecond Price Monitoring Extn
15th Jul 20219:00 amRNSPrice Monitoring Extension
15th Jul 20217:00 amRNSResults of Fundraise
14th Jul 20214:53 pmRNSPlacing, Subscription, Retail Offer & Open Offer
14th Jul 20214:36 pmRNSRetail Offer by PrimaryBid
14th Jul 20214:35 pmRNSOpen Offer of Ordinary Shares
7th Jul 20219:05 amRNSSecond Price Monitoring Extn
7th Jul 20219:00 amRNSPrice Monitoring Extension
7th Jul 20217:21 amRNSProgressive publishes new research
7th Jul 20217:00 amRNSAward of Block XX Exploitation Licence
22nd Jun 20217:00 amRNS2020 Full Year Financial Results
12th May 20212:06 pmRNSSecond Price Monitoring Extn
12th May 20212:01 pmRNSPrice Monitoring Extension
10th May 20217:00 amRNSBlock XX Exploitation Licence Update
23rd Apr 20214:40 pmRNSSecond Price Monitoring Extn
23rd Apr 20214:35 pmRNSPrice Monitoring Extension
23rd Apr 20212:06 pmRNSSecond Price Monitoring Extn
23rd Apr 20212:00 pmRNSPrice Monitoring Extension
22nd Apr 20212:06 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:00 pmRNSPrice Monitoring Extension
21st Apr 20212:05 pmRNSSecond Price Monitoring Extn
21st Apr 20212:00 pmRNSPrice Monitoring Extension
19th Apr 20212:06 pmRNSSecond Price Monitoring Extn
19th Apr 20212:00 pmRNSPrice Monitoring Extension
12th Apr 202111:13 amRNSReplacement - Block XX Exploration Licence Update
12th Apr 20217:00 amRNSBlock XX Exploration Licence Update
7th Apr 20214:41 pmRNSSecond Price Monitoring Extn
7th Apr 20214:36 pmRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSBlock XX Operational Update
5th Jan 202111:05 amRNSSecond Price Monitoring Extn
5th Jan 202111:00 amRNSPrice Monitoring Extension
5th Jan 20217:00 amRNSBlock XX Exploitation Licence Application Update
31st Dec 202011:05 amRNSSecond Price Monitoring Extn
31st Dec 202011:00 amRNSPrice Monitoring Extension
30th Dec 20204:41 pmRNSSecond Price Monitoring Extn
30th Dec 20204:36 pmRNSPrice Monitoring Extension
30th Dec 20202:05 pmRNSSecond Price Monitoring Extn
30th Dec 20202:00 pmRNSPrice Monitoring Extension
21st Dec 20204:18 pmRNSCorrection: Total Voting Rights
21st Dec 20207:00 amRNSConditional Share Awards and Total Voting Rights
10th Dec 202011:18 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.